The Center for Genetics and Society brings social justice and human rights to the center of public and policy discussions about human genetics and assisted reproduction.

Featured

Biopolitical Times

Group of Tuskegee Experiment test subjects
Public Domain via Wikimedia Commons

Every generation needs to learn about what is commonly known as the Tuskegee syphilis study, which ran from 1932 to 1972. (Officially, it was the U.S. Public Health Service Syphilis Study at Tuskegee, Alabama, which gets the emphasis right.) For many people, the history is hard to believe, though it is hardly unique. Of the 600 subjects, all Black men, 399 had syphilis, for which...

Aggregated News

This is the 10th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by Osagie K. Obasogie in...

Aggregated News

There is growing concern that falling fertility rates will lead to economic and demographic catastrophe. The social and political movement...

Aggregated News

In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby...

Biopolitical Times

Last month, we published “The Shameful Legacy of Tuskegee” which focused on a proposed experiment in Guinea-Bissau. The...

Group of Tuskegee Experiment test subjects
Public Domain via Wikimedia Commons

Every generation needs to learn about what is commonly...

Following a long-standing CGS tradition, we present a selection of our favorite Biopolitical Times posts of the past year.

In...

News

The reproductive tech company Orchid recently launched a genetic test that promises a whole genome sequencing report for embryos. It is the first such test commercially available to couples undergoing in vitro fertilization (IVF) and claims to detect things like...

Who gets to be "hot" in America? And, at what cost?

Some young men are pushing beauty boundaries with guidance from an online trend that's been making headlines: looksmaxxing. Looksmaxxing celebrates intense fitness & skincare routines, extreme body modification, and...

Millions of people struggle to become pregnant in the U.S. And in 2024, fertility rates reached a new low, according to CDC data. Women are also waiting longer to have kids, while a growing number are deciding to opt out...

The FDA is spelling out the details of a new pathway to help speed personalized cell and gene therapies to market for rare diseases.

Monday’s long-awaited draft guidance outlines the agency’s “plausible mechanism” framework, a pathway FDA Commissioner Marty Makary...

Video

Reproduction and Family Formation: The State and the Market
Use Gene Editing to Make Better Babies | Debate | Intelligence Squared U.S.
The 'Perfect' Baby?: The Dangers of Gene Editing in Assisted Reproduction